Cargando…
Ivabradine – the first selective sinus node I(f) channel inhibitor in the treatment of stable angina
Heart rate, a major determinant of angina in coronary disease, is also an important predictor of cardiovascular mortality. Lowering heart rate is therefore one of the most important therapeutic approaches in the treatment of stable angina pectoris. To date, β-blockers and some calcium-channel antago...
Autores principales: | Sulfi, S, Timmis, AD |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1448693/ https://www.ncbi.nlm.nih.gov/pubmed/16451297 http://dx.doi.org/10.1111/j.1742-1241.2006.00817.x |
Ejemplares similares
-
Effectiveness of Ivabradine in Treating Stable Angina Pectoris
por: Ye, Liwen, et al.
Publicado: (2016) -
Ivabradine for the Therapy of Chronic Stable Angina Pectoris
por: Kim, Soo-Joong
Publicado: (2020) -
Management of Stable Angina with Ivabradine as Safe Alternative to Patients with Myasthenia Gravis
por: Ohde Dalledone, Giuliano, et al.
Publicado: (2016) -
Role of ivabradine in management of stable angina in patients with different clinical profiles
por: Kaski, Juan Carlos, et al.
Publicado: (2018) -
Comparison of the efficacy and tolerability of ivabradine and ranolazine in patients of chronic stable angina pectoris
por: Chaturvedi, Aditi, et al.
Publicado: (2013)